Pharmaceutical

Activist investor Bluebell takes stake in GSK

A GlaxoSmithKline factory is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan / Pool via REUTERS / File Photo Sept. 22 (Reuters) – Activist investor Bluebell Capital Partners has taken an estimated € 10million stake in UK pharmaceutical group GlaxoSmithKline (GSK.L) in a bid to shake up management, …

Read More »

FDA Approves Incyte Eczema Cream with Boxed Warnings

Signage can be seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, USA on August 29, 2020. REUTERS / Andrew Kelly Sept. 21 (Reuters) – The U.S. Food and Drug Administration on Tuesday approved Opzelura Cream from Incyte Corp (INCY.O) for the treatment of inflammatory atopic …

Read More »

Leading Microbiologists to Meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference

SMi Reports: Leading Pharmaceutical Microbiologists and Industry Experts to Meet at SMi Pharmaceutical Microbiology UK 10th Anniversary Conference LONDON, GREATER LONDON, UK, September 20, 2021 /EINPresswire.com/ – SMi Group announces the 10th Annual UK Pharmaceutical Microbiology Conference to be held January 17-18, 2022 in London. The theme of the 10th …

Read More »

Egyptian Medicines Authority and South Korea plan to improve pharmaceutical cooperation

Tamer Essam, chairman of the Egyptian Medicines Authority (EDA), met South Korean Ambassador to Cairo Hong Jin Wook to discuss strengthening medical and pharmaceutical cooperation between the two countries. At Saturday’s meeting, Ambassador Hong praised EDA’s role in meeting Egypt’s needs for medical supplies, despite the challenges resulting from the …

Read More »

Spectrum Pharmaceuticals Presents Late-Breaking Oral Presentation of Poziotinib Data in First-Line NSCLC Patients with Exon 20 HER2 Insertion Mutations at ESMO 2021

Initial data from cohort 4 of the ongoing ZENITH20 clinical trial show 44% ORR in 48 first-line patients treated with 16 mg poziotinib once daily HENDERSON, Nevada, September 18, 2021– (BUSINESS WIRE) – Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company specializing in innovative and targeted oncology therapies, today announced …

Read More »